Peptide V3 Inhibits the Growth of Human Hepatocellular Carcinoma by Inhibiting the Ras/Raf/MEK/ERK Signaling Pathway

In conclusion, peptide V3 could inhibit the growth of human HCC by inhibiting the Ras/Raf/MEK/ERK signaling pathway. Novel peptides and modification strategies could be designed and applied for the treatment of different types of cancer.

Source: Journal of Cancer - June 13, 2019 Category: Cancer & Oncology Authors: Dongdong Wu, Mengling Li, Yingran Gao, Wenke Tian, Jianmei Li, Qianqian Zhang, Zhengguo Liu, Mengli Zheng, Hongju Wang, Jun Wang, Tieshan Teng, Lei Zhang, Xinying Ji, Zhongwen Xie, Ailing Ji, Yanzhang Li Tags: Research Paper Source Type: research